Literature DB >> 25641509

Are transcutaneous oxygen and carbon dioxide determinations of value in pulmonary arterial hypertension?

Adriano R Tonelli1, Laith Alkukhun, Frank Cikach, Mostafa Ahmed, Raed A Dweik.   

Abstract

BACKGROUND: We hypothesized that transcutaneous gas determinations of O2 and CO2 (TcPO2 and TcPCO2 ) are associated with the severity of PAH.
METHODS: In this cross-sectional study, we included consecutive patients with PAH (group 1 PH; n = 34). Transcutaneous gas determinations were compared to those of age- and gender-matched healthy controls (n = 14), nongroup 1 PH (n = 19) or patients with high estimated RVSP on echocardiography but without hemodynamic evidence of PH (n = 12).
RESULTS: In patients with PAH, TcPO2 , and TcPCO2 were significantly associated with PaO2 (R = 0.44, p = 0.03) and PaCO2 (R = 0.77, p < 0.001), respectively. TcPO2 /FiO2 (mean difference: -65.0 [95% CI: -121.3, -8.7]) and TcPCO2 (mean difference: -7.4 [95% CI: -11.6, -3.1]) were significantly lower in patients with PAH than healthy controls. TcPCO2 was useful in discriminating PAH patients from other individuals (AUC: 0.74 [95% CI: 0.62, 0.83]). TcPO2 /FiO2 ratio was significantly associated with mean PAP, TPG, PVR, CI, SVI, DLCO, six-minute walk distance and components of the CAMPHOR questionnaire.
CONCLUSIONS: Transcutaneous pressure of CO2 was lower in patients with PAH. Transcutaneous pressure of O2 over inspired fraction of O2 ratio was inversely associated with severity of disease in patients with PAH.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  arterial blood gases; carbon dioxide; microcirculation; oxygen; pulmonary arterial hypertension; transcutaneous oxygenation; vascular function

Mesh:

Substances:

Year:  2015        PMID: 25641509      PMCID: PMC4411192          DOI: 10.1111/micc.12191

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  27 in total

Review 1.  Definitions and diagnosis of pulmonary hypertension.

Authors:  Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

Review 2.  Updated clinical classification of pulmonary hypertension.

Authors:  Gerald Simonneau; Michael A Gatzoulis; Ian Adatia; David Celermajer; Chris Denton; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; R Krishna Kumar; Michael Landzberg; Roberto F Machado; Horst Olschewski; Ivan M Robbins; Rogiero Souza
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

3.  Sublingual microcirculation in pulmonary arterial hypertension.

Authors:  Luma Dababneh; Frank Cikach; Laith Alkukhun; Raed A Dweik; Adriano R Tonelli
Journal:  Ann Am Thorac Soc       Date:  2014-05

4.  Transcutaneous oxygen tension and capillary morphologic characteristics and density in patients with chronic venous incompetence.

Authors:  U K Franzeck; A Bollinger; R Huch; A Huch
Journal:  Circulation       Date:  1984-11       Impact factor: 29.690

5.  The clinical utility of arterialized earlobe capillary blood in the assessment of patients for long-term oxygen therapy.

Authors:  T Eaton; S Rudkin; J E Garrett
Journal:  Respir Med       Date:  2001-08       Impact factor: 3.415

6.  Accuracy of a transcutaneous carbon dioxide pressure monitoring device in emergency room patients with acute respiratory failure.

Authors:  P-E Gancel; E Roupie; L Guittet; S Laplume; N Terzi
Journal:  Intensive Care Med       Date:  2010-11-11       Impact factor: 17.440

7.  Causes and circumstances of death in pulmonary arterial hypertension.

Authors:  Adriano R Tonelli; Vineesha Arelli; Omar A Minai; Jennie Newman; Nancy Bair; Gustavo A Heresi; Raed A Dweik
Journal:  Am J Respir Crit Care Med       Date:  2013-08-01       Impact factor: 21.405

8.  AARC clinical practice guideline: transcutaneous monitoring of carbon dioxide and oxygen: 2012.

Authors:  Ruben D Restrepo; Keith R Hirst; Leonard Wittnebel; Richard Wettstein
Journal:  Respir Care       Date:  2012-11       Impact factor: 2.258

9.  Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing.

Authors:  Roland Wensel; Christian F Opitz; Stefan D Anker; Jörg Winkler; Gert Höffken; Franz X Kleber; Rakesh Sharma; Manfred Hummel; Roland Hetzer; Ralf Ewert
Journal:  Circulation       Date:  2002-07-16       Impact factor: 29.690

10.  Primary pulmonary hypertension. A national prospective study.

Authors:  S Rich; D R Dantzker; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; S K Koerner
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

View more
  2 in total

1.  Treprostinil Iontophoresis in Idiopathic Pulmonary Arterial Hypertension.

Authors:  Adriano R Tonelli; Mostafa K Ahmed; Laith Alkukhun; Frank Cikach; Kulwant Aulak; Raed A Dweik
Journal:  Am J Respir Crit Care Med       Date:  2015-10-15       Impact factor: 21.405

Review 2.  Novel methods in pulmonary hypertension phenotyping in the age of precision medicine (2015 Grover Conference series).

Authors:  Jarrod W Barnes; Adriano R Tonelli; Gustavo A Heresi; Jennie E Newman; Noël E Mellor; David E Grove; Raed A Dweik
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.